BRPI0510951A - derivados de piperidina como antagonistas de nk1 e nk3 - Google Patents
derivados de piperidina como antagonistas de nk1 e nk3Info
- Publication number
- BRPI0510951A BRPI0510951A BRPI0510951-5A BRPI0510951A BRPI0510951A BR PI0510951 A BRPI0510951 A BR PI0510951A BR PI0510951 A BRPI0510951 A BR PI0510951A BR PI0510951 A BRPI0510951 A BR PI0510951A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- heterocycloalkyl
- independently selected
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 150000003053 piperidines Chemical class 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 3
- -1 -NO ~ 2 ~ Chemical group 0.000 abstract 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
DERIVADOS DE PIPERIDINA COMO ANTAGONISTAS DE NKl E NK3 A invenção está relacionada a compostos de acordo com a fórmula I que exibem propriedades inibitórias de neurocinina, uma composição farmacêutica compreendendo, o mesmo e um método de tratamento para condições mediadas por neurocinina. Fórmula (I) ou um sal farmaceuticamente aceitável ou solvato da mesma onde: m = 0 ou 1; n = 0 ou 1; 5 = 0 ou 1; L é -O- ou -N(R¬ 4¬)-; R¬ 1¬ e R¬ 2¬ são, cada um, independentemente H, arila, heteroarila, -alquila (C~ 1~-C~ 6~) heterocicloalquila, -alquila (C~ 1~-C~ 6~) heterocicloalquila, -alquila (C~ 1~-C~ 6~) heteroarila, -alquila (C~ 1~-C~ 6~) - O-arila, alquila (C~ 1~-C~ 6~) arila, e -H~ 2~N(R¬ 4¬) (R¬ 5¬), onde cada uma das referidas heterocicloalquila, -alquila (C~ 1~-C~ 6~) hetzerocicloalquila, -alquila (C~ 1~-C~ 6~) heteroarila, -alquila (C~ 1~-C~ 6~) -0-arila, arila, -alquila (C~ 1~-C~ 6~) arila, heteroarila, e -CH~ 2~N (R¬ 4¬) (R¬ 5¬), é opcionalmente substituída com 1 a 3 frações independentemente selecionadas de X<39>, Y<39> ou Z <39>; R¬ 3¬ é H, CF~ 3~, OH, ou -alquila (C~ 1~-C~ 6~); R¬ 4¬, e R¬ 5¬, são, cada um, independentemente selecionados de H, -alquila (C~ 1~-C~ 6~), ou - (C~ 1~-C~ 6~) (C=O) R¬ 7¬; R¬ 7¬ é alquila (C~ 1~-C~ 6~ ), OH, -N(R¬ 4¬) (R¬ 5¬), ou -OR¬ 4¬; R¬ 8¬ e R~ 9¬ são, cada um, independentemente alquila (C~ 1~-C~ 6~); X, Y, X<39>, Y<39> e Z<39> são, cada um, independentemente selecionados de H, -alquila (C~ 1~-C~ 6~), -alquila (C~ 1~-C~ 6~) -NR¬ 4¬R¬ 5¬, CF~ 3~, OH, -O-alquila (C~ 1~-C~ 6~), -alquila (C~ 1~-C~ 6~) - C(=O) R¬ 7¬, arila, heteroarila, cicloalquila, -NO~ 2~, -alquila (C~ 1~-C~6~) arila, -O-arila, halogênio, CN, -CH~ 3~N(R¬ 4¬) (R¬ 5¬), -C(=O)R¬ 7¬, -C(=O)R¬ 7¬, -R¬ 6¬C(=O)R¬ 7¬ ou -R¬ 6¬C(=O) NR¬ 4¬R¬ 5~; e R¬ 6¬ é uma ligação, -CH~ 2~-, -O-, ou -NR¬ 4¬-.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57050804P | 2004-05-12 | 2004-05-12 | |
PCT/IB2005/001198 WO2005110987A1 (en) | 2004-05-12 | 2005-04-29 | Piperidine derivatives as nk1 and nk3 antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0510951A true BRPI0510951A (pt) | 2007-11-20 |
Family
ID=34966231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510951-5A BRPI0510951A (pt) | 2004-05-12 | 2005-04-29 | derivados de piperidina como antagonistas de nk1 e nk3 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050256164A1 (pt) |
EP (1) | EP1748984A1 (pt) |
JP (1) | JP2007537233A (pt) |
BR (1) | BRPI0510951A (pt) |
CA (1) | CA2565953A1 (pt) |
MX (1) | MXPA06013162A (pt) |
WO (1) | WO2005110987A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2586883A1 (en) * | 2004-11-22 | 2006-06-01 | Merck & Co., Inc. | Piperidinyl piperidine tachykinin receptor antagonists |
TW200716603A (en) * | 2005-04-21 | 2007-05-01 | Takeda Pharmaceuticals Co | Piperidine derivative crystal, process for producing the same, and use |
WO2006115285A1 (ja) * | 2005-04-21 | 2006-11-02 | Takeda Pharmaceutical Company Limited | 医薬組成物 |
JP2009502739A (ja) * | 2005-08-04 | 2009-01-29 | 武田薬品工業株式会社 | タキキニン受容体拮抗剤としてのピペリジン誘導体 |
CA2636946A1 (en) * | 2006-01-11 | 2007-07-19 | Merck And Co., Inc. | Fused triazole tachykinin receptor antagonists |
DE602008003221D1 (de) * | 2007-06-07 | 2010-12-09 | Hoffmann La Roche | Prolinamidderivate als nk3-antagonisten |
WO2009072643A1 (en) * | 2007-12-03 | 2009-06-11 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound and use thereof |
US8063075B2 (en) * | 2008-06-10 | 2011-11-22 | Hoffmann-La Roche Inc. | Pyrrolidine ether derivatives as NK3 receptor antagonists |
USRE48334E1 (en) | 2008-09-19 | 2020-12-01 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound and use of same |
CA2738870A1 (en) * | 2008-10-09 | 2010-04-15 | F. Hoffmann-La Roche Ag | Pyrrolidine n-benzyl derivatives |
SG173114A1 (en) * | 2009-01-30 | 2011-08-29 | Hoffmann La Roche | Piperidine derivatives as nk3 receptor antagonists |
US9446029B2 (en) * | 2010-07-27 | 2016-09-20 | Colorado State University Research Foundation | Use of NK-1 receptor antagonists in management of visceral pain |
GB201116335D0 (en) * | 2011-09-21 | 2011-11-02 | Novaremed Ltd | A method of treating or preventing affective disorders |
JP6420074B2 (ja) * | 2013-06-27 | 2018-11-07 | 国立大学法人京都大学 | プテロシン誘導体を含む軟骨欠損、軟骨変性、および/または軟骨菲薄疾患治療剤 |
PL3297631T3 (pl) | 2015-05-18 | 2020-03-31 | Nerre Therapeutics Limited | Antagoniści receptora NK-1/NK-3 do leczenia uderzeń gorąca |
PT3765024T (pt) | 2018-03-14 | 2024-02-19 | Kandy Therapeutics Ltd | Formulação farmacêutica inovadora que compreende antagonistas duplos dos recetores nk-1/nk-3 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1542649A (fr) * | 1966-08-18 | 1968-10-18 | Sandoz Sa | Naphtyridines et leur préparation |
CH485756A (de) * | 1966-10-07 | 1970-02-15 | Sandoz Ag | Verfahren zur Herstellung neuer Naphthyridin-Derivate |
GB1304589A (pt) * | 1969-05-06 | 1973-01-24 | ||
DE2016268C3 (de) * | 1970-04-06 | 1980-10-09 | Sandoz-Patent-Gmbh, 7850 Loerrach | (4aRS, 5SR, 9bSR)- und (4aRS, 5SR, 9bRS) -13,4,4a3,9b-Hexahydro-5-phenyl2H-indeno [Uc] pyridine, ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel |
CH526546A (de) * | 1970-04-08 | 1972-08-15 | Sandoz Ag | Verfahren zur Herstellung neuer 3-Phenylpiperidinderivate |
DE2116316A1 (de) * | 1970-04-08 | 1971-10-28 | Sandoz Ag, Basel (Schweiz) | Verfahren zur Herstellung neuer heterocyclischer Verbindungen |
CH529756A (de) * | 1970-04-08 | 1972-10-31 | Sandoz Ag | Verfahren zur Herstellung neuer 3-Phenylpiperidinderivate |
GB1361441A (en) * | 1970-05-13 | 1974-07-24 | Sandoz Ltd | Benzonaphthyridine derivatives |
US4132709A (en) * | 1976-12-20 | 1979-01-02 | Ayerst, Mckenna & Harrison, Ltd. | [2]Benzopyrano[4,3-c]pyridine derivatives and process therefor |
DE2802306A1 (de) * | 1977-01-27 | 1978-08-10 | Hoechst Ag | Azacycloalkane, azacycloalkene und ihre derivate |
US4216218A (en) * | 1979-02-23 | 1980-08-05 | American Hoechst Corporation | Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines |
US4312876A (en) * | 1979-02-23 | 1982-01-26 | Hoechst-Roussel Pharmaceuticals Incorporated | Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines |
DE4217401A1 (de) * | 1991-06-07 | 1993-01-28 | Byk Gulden Lomberg Chem Fab | Verfahren zur herstellung von 4-aminopiperidinen |
JP2953653B2 (ja) * | 1997-05-21 | 1999-09-27 | 沢井製薬株式会社 | ピペリジン誘導体の製造方法 |
EP1553084A4 (en) * | 2002-05-31 | 2007-03-28 | Takeda Pharmaceutical | PIPERIDINE DERIVATIVE, PROCESS FOR PRODUCTION, AND USE |
-
2005
- 2005-04-29 BR BRPI0510951-5A patent/BRPI0510951A/pt not_active IP Right Cessation
- 2005-04-29 MX MXPA06013162A patent/MXPA06013162A/es unknown
- 2005-04-29 JP JP2007512554A patent/JP2007537233A/ja not_active Withdrawn
- 2005-04-29 EP EP05731777A patent/EP1748984A1/en not_active Withdrawn
- 2005-04-29 CA CA002565953A patent/CA2565953A1/en not_active Abandoned
- 2005-04-29 WO PCT/IB2005/001198 patent/WO2005110987A1/en active Application Filing
- 2005-05-06 US US11/123,331 patent/US20050256164A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2565953A1 (en) | 2005-11-24 |
MXPA06013162A (es) | 2007-02-13 |
US20050256164A1 (en) | 2005-11-17 |
JP2007537233A (ja) | 2007-12-20 |
WO2005110987A1 (en) | 2005-11-24 |
EP1748984A1 (en) | 2007-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510951A (pt) | derivados de piperidina como antagonistas de nk1 e nk3 | |
AR037418A1 (es) | Derivados de benzotiazol | |
EA200700141A1 (ru) | Новые аминоциклические производные мочевины, их получение и фармацевтическое применение в качестве ингибиторов киназы | |
NO20063928L (no) | Substituerte kinolinforbindelser | |
ATE517882T1 (de) | Chinolinderivate | |
NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
AR036044A1 (es) | Compuestos piranoindazoles, composiciones farmaceuticas y su uso para la manufactura de un medicamento para el tratamiento del glaucoma | |
PE20080677A1 (es) | Inhibidores de pirrolotriazina cinaza | |
DOP2005000071A (es) | "compuestos de metil-aril o heteroaril-amida sustituida" | |
PE20080139A1 (es) | Compuestos de pirrolotriazina anilina como inhibidores de cinasa | |
AR063581A1 (es) | Imidazopirazinas como inhibidores de proteina quinasa | |
MX2008002061A (es) | Derivados de tiazolil piperidina utiles como moduladores del receptor h3. | |
AR069271A1 (es) | Dihidrobenzo(1, 4)dioxinas sustituidas, una composicion farmaceutica que las comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por el antagonismo de alfa2c. | |
AR059136A1 (es) | Derivados de indol-3-il-carbonil-espiro-piperidina | |
DE602005022764D1 (de) | Piperidin- und azetidinderivate als glyt1-inhibitoren | |
BRPI0515991A (pt) | derivados de bisariluréia substituìda heterocìclica como inibidores de cinase | |
EA200701035A1 (ru) | Замещенные n-сульфониламинобензил-2-феноксиацетамидные соединения | |
AR074204A1 (es) | Arilpiperazinas y su uso como antagonistas alfa -2c | |
BRPI0409739A (pt) | composto, composição farmacêutica, uso de composto, e, método para o tratamento de uma doença ou de um distúrbio | |
EA200300071A1 (ru) | Терапевтический препарат для лечения невроза страха (тревоги) или депрессии и производные пиперазина | |
NO20060718L (no) | Substituerte tiofoner og deres anvendelse | |
DE602004027409D1 (de) | Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation | |
AR057197A1 (es) | Derivados de 1, 1-dioxo-tiomorfolinil-indolil-metanona | |
PE20010751A1 (es) | Quinolin-2-ona como inhibidores de las proteinas resistentes a multiples farmacos | |
AR057975A1 (es) | DERIVADOS DE QUINAZOLINAS, PROCESO DE OBTENCIoN Y COMPOSICIONES FARMACEUTICAS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A E 6A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE A 8.6 NA RPI 2099 DE 29/03/2011. |